Biology of the papillomavirus E5 oncoprotein family

乳头瘤病毒 E5 癌蛋白家族的生物学

基本信息

  • 批准号:
    7771629
  • 负责人:
  • 金额:
    $ 39.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-01-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

The high-risk papillomaviruses are critical etiologic agents in human malignancy, most importantly in cervical cancer. These oncogenic viruses encode the E6 and E7 proteins that have been shown to modulate cell growth.and differentiation, target the p53 and Rb tumor suppressor proteins, and induce the hTERT gene and cellular immortalization. In addition to the E6 and E7 proteins, the high-risk papillomaviruses also encode the hydrophobic, membrane-associated E5 protein. In recent months, several studies have established that the evolution of the E5 protein is tightly linked to that of the E6 protein and that the E5 genes of high-risk papillomaviruses have characteristics that separate them from those of low-risk viruses. The high-risk HPV-16 E5 protein has a wide spectrum of biological activities, ranging from alterations of growth factor receptor turnover, MHC transport, endosome acidification, anchorage-independent growth, and intercellular junction communication. Previously we have shown that the E5 protein binds a component of the V-ATPase complex and interferes with endosome acidification, thereby giving some insight into how E5 might potentiate the signaling of growth factor receptors. In the current proposal, we have discovered additional targets for E5, including caveolin and a 116 kDa cellular protein. Based upon our accumulated knowledge regarding the detergent solubility properties of E5 and the identified E5-associated proteins, we hypothesize that E5 partitions into membrane lipid rafts and associateswith proteins that are resident in these signaling platforms. We have constructed a model that conceptually links the identified E5 targets with the plethora of known E5-induced cellular phenotypes and have designed experiments based upon this model. The specific delineation of how E5 is targeted to rafts, how it binds to specific raft-resident proteins, and how is interferes with the functions of these proteins is the focus of this grant. It is anticipated that insights into E5 functions will illuminate its linkage to HPV-induced malignancy.
高危型乳头瘤病毒是人类恶性肿瘤的重要病原体,尤其是宫颈癌。 癌这些致癌病毒编码的E6和E7蛋白已被证明可以调节细胞凋亡。 生长和分化,靶向p53和Rb肿瘤抑制蛋白,并诱导hTERT基因 和细胞永生化。除了E6和E7蛋白,高危乳头瘤病毒还 编码疏水性膜相关E5蛋白。近几个月来,一些研究 E5蛋白的进化与E6蛋白的进化紧密相连, 高风险的乳头状瘤病毒具有将它们与低风险病毒区分开的特征。的 高危型HPV-16 E5蛋白具有广泛的生物学活性, 因子受体周转,MHC转运,内体酸化,锚定非依赖性生长, 细胞间连接通讯以前我们已经表明,E5蛋白结合的一个组成部分, V-ATP酶复合物,并干扰内体酸化,从而对E5 可能会增强生长因子受体的信号传导。在目前的提案中,我们发现 E5的其他靶点,包括小窝蛋白和116 kDa细胞蛋白。根据我们积累的 关于E5的去污剂溶解特性和鉴定的E5相关蛋白的知识,我们 假设E5分配到膜脂筏中,并与驻留在膜脂筏中的蛋白质结合, 这些信号平台。我们已经构建了一个模型,在概念上将已识别的E5靶点与 过多的已知E5诱导的细胞表型,并基于此设计了实验 模型E5如何靶向筏的具体描述,它如何与特定的筏驻留蛋白结合, 以及它是如何干扰这些蛋白质的功能的,是这项资助的重点。预计各国 对E5功能的深入了解将阐明其与HPV诱导的恶性肿瘤的联系。

项目成果

期刊论文数量(41)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18.
肿瘤坏死因子对原代人角质形成细胞和含有人乳头瘤病毒 16 型和 18 型的细胞系增殖的差异作用。
  • DOI:
    10.1002/mc.2940060103
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Villa,LL;Vieira,KB;Pei,XF;Schlegel,R
  • 通讯作者:
    Schlegel,R
The BPV-1 E5 oncoprotein expressed in Schizosaccharomyces pombe exhibits normal biochemical properties and binds to the endogenous 16-kDa component of the vacuolar proton-ATPase.
粟酒裂殖酵母中表达的 BPV-1 E5 癌蛋白表现出正常的生化特性,并与液泡质子 ATP 酶的内源 16 kDa 成分结合。
  • DOI:
    10.1016/0042-6822(92)90932-f
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Goldstein,DJ;Toyama,R;Dhar,R;Schlegel,R
  • 通讯作者:
    Schlegel,R
Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes.
  • DOI:
  • 发表时间:
    1994-02
  • 期刊:
  • 影响因子:
    8
  • 作者:
    K. Steinmann;X. Pei;H. Stöppler;R. Schlegel
  • 通讯作者:
    K. Steinmann;X. Pei;H. Stöppler;R. Schlegel
The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.
丝氨酸蛋白酶抑制剂 TLCK 和 TPCK 与 HPV-18 E7 蛋白的 RB 结合核心发生反应,并消除其 RB 结合能力。
  • DOI:
    10.1006/viro.1996.0149
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Stoppler,H;Stoppler,MC;Adduci,A;Koval,D;Schlegel,R
  • 通讯作者:
    Schlegel,R
The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
  • DOI:
    10.1371/journal.ppat.1001089
  • 发表时间:
    2010-09-02
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Wang J;Zhou D;Prabhu A;Schlegel R;Yuan H
  • 通讯作者:
    Yuan H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Schlegel其他文献

Richard Schlegel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Schlegel', 18)}}的其他基金

Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
  • 批准号:
    8899468
  • 财政年份:
    2013
  • 资助金额:
    $ 39.53万
  • 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
  • 批准号:
    8727495
  • 财政年份:
    2013
  • 资助金额:
    $ 39.53万
  • 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
  • 批准号:
    8547303
  • 财政年份:
    2013
  • 资助金额:
    $ 39.53万
  • 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
  • 批准号:
    8516613
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
  • 批准号:
    8725249
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
  • 批准号:
    8322566
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
  • 批准号:
    8137493
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
  • 批准号:
    7286845
  • 财政年份:
    2006
  • 资助金额:
    $ 39.53万
  • 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
  • 批准号:
    7174571
  • 财政年份:
    2006
  • 资助金额:
    $ 39.53万
  • 项目类别:
HPV E6 protein regulation of the hTERT promoter
HPV E6 蛋白对 hTERT 启动子的调节
  • 批准号:
    6757107
  • 财政年份:
    2004
  • 资助金额:
    $ 39.53万
  • 项目类别:

相似海外基金

Role of anchorage-independent growth regulation in tumor progression
不依赖锚定的生长调节在肿瘤进展中的作用
  • 批准号:
    15K06829
  • 财政年份:
    2015
  • 资助金额:
    $ 39.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anchorage-independent growth and EMT relationship in esophageal cancer.
食管癌的锚定非依赖性生长和 EMT 关系。
  • 批准号:
    23659637
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Understanding the molecular mechanism required for an anchorage-independent growth of CD133-positive ovarian cancer cells
了解 CD133 阳性卵巢癌细胞非贴壁依赖性生长所需的分子机制
  • 批准号:
    23800055
  • 财政年份:
    2011
  • 资助金额:
    $ 39.53万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Functional analysis of a novel signal molecule CDCP1 which regulates anchorage-independent growth in cancer cells
调节癌细胞贴壁依赖性生长的新型信号分子CDCP1的功能分析
  • 批准号:
    21590350
  • 财政年份:
    2009
  • 资助金额:
    $ 39.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiology of lymphatic stomata in the pathogenesis of cancerous pleural effusion and mechanisms of anchorage-independent growth of cancer
癌性胸腔积液发病机制中淋巴气孔的病理生理学和癌症非锚定依赖性生长机制
  • 批准号:
    20790993
  • 财政年份:
    2008
  • 资助金额:
    $ 39.53万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
  • 批准号:
    6513557
  • 财政年份:
    2000
  • 资助金额:
    $ 39.53万
  • 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
  • 批准号:
    6633392
  • 财政年份:
    2000
  • 资助金额:
    $ 39.53万
  • 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
  • 批准号:
    6042591
  • 财政年份:
    2000
  • 资助金额:
    $ 39.53万
  • 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
  • 批准号:
    6377153
  • 财政年份:
    2000
  • 资助金额:
    $ 39.53万
  • 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
  • 批准号:
    6771684
  • 财政年份:
    2000
  • 资助金额:
    $ 39.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了